Cupric cation

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Cupric cation
DrugBank Accession Number
DB14552
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 63.546
Monoisotopic: 62.929601079
Chemical Formula
Cu
Synonyms
  • Copper ion (Cu++)
  • Copper ions
  • copper(2+)
  • Copper(2+)ions
  • Cupric ion

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Moms Choice RxCupric cation (2 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (2840 [iU]/1) + Calcium carbonate (215 mg/1) + Cholecalciferol (840 [iU]/1) + Cyanocobalamin (.012 mg/1) + D-alpha-Tocopherol acetate (2 mg/1) + Folic acid (1 mg/1) + Iodine (.223 mg/1) + Iron (26 mg/1) + Magnesium (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (278 mg/1) + Pyridoxine hydrochloride (50 mg/1) + Riboflavin (4 mg/1) + Thiamine chloride (1.5 mg/1) + Zinc oxide (25 mg/1)KitOralPru Gen Pharmaceuticals2013-04-01Not applicableUS flag

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of inorganic compounds known as homogeneous transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a transition metal atom.
Kingdom
Inorganic compounds
Super Class
Homogeneous metal compounds
Class
Homogeneous transition metal compounds
Sub Class
Not Available
Direct Parent
Homogeneous transition metal compounds
Alternative Parents
Not Available
Substituents
Homogeneous transition metal
Molecular Framework
Not Available
External Descriptors
monoatomic dication, divalent metal cation, copper cation (CHEBI:29036) / a cation (CU+2)
Affected organisms
Not Available

Chemical Identifiers

UNII
8CBV67279L
CAS number
15158-11-9
InChI Key
JPVYNHNXODAKFH-UHFFFAOYSA-N
InChI
InChI=1S/Cu/q+2
IUPAC Name
copper(2+) ion
SMILES
[Cu++]

References

General References
Not Available
Human Metabolome Database
HMDB0000657
ChemSpider
25221
RxNav
1427198
ChEBI
29036
ChEMBL
CHEMBL55643
PDBe Ligand
CU
PDB Entries
1a2v / 1a4a / 1a4b / 1a4c / 1a65 / 1a8v / 1aac / 1aan / 1adw / 1ag0
show 1897 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
KitOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0.16Chemaxon
pKa (Strongest Acidic)3.09Chemaxon
Physiological Charge2Chemaxon
Hydrogen Acceptor Count0Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area0 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity0 m3·mol-1Chemaxon
Polarizability1.78 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at July 13, 2018 18:05 / Updated at June 12, 2020 16:53